2016 Stories

Note: Links to these online articles may no longer be active. They are provided here as a reference only. They may continue to be available via the host site's archive.

Hope for Eye Patients Seen in Common Drug
February 5, 2016 (Boston Herald)
Edward Brown, an amateur photographer from Quincy, thought he had captured the last of his nighttime cityscapes when he was diagnosed with a disease that could eventually leave him blind. But eight years later, Brown’s vision has actually improved — and researchers at Massachusetts Eye and Ear say high doses of a common cholesterol medication have helped achieve the unthinkable in reversing Brown’s macular degeneration.

Cholesterol Drug Could Restore Vision In Patients With Age-Related Macular Degeneration, Study Suggests
February 5, 2016 (Huffington Post Lifestyle (UK))
A drug commonly used to lower cholesterol could help restore vision in patients suffering from age-related macular degeneration (AMD). The health condition currently affects more than 600,000 people in the UK and is the leading cause of vision loss. A small clinical trial of people with AMD found high-dose treatment with the statin Lipitor cleared away fatty deposits behind the retina. This led to visual improvement in almost half of patients. Researchers believe the drug has the potential to halt progression of the disease.

Wakefield Company Uses New Scanning Technology To Make Custom Earbuds
January 14, 2016 (WBZ-TV News, Boston)

Uvero, a Wakefield, Mass.-based company, uses an MIT-developed scanning technique to create a digital map of the inner ear that enables the company to build custom-fit earbuds for clients. Not only do the customized earbuds offer a more comfortable experience, but the company also claims that they enable users to lower their music volume to a safer level that won't lead to hearing loss. “It’s comparable to wearing sunglasses on a bright sunny day," explains Steven Rauch, M.D. "You’re reducing the amount of noise exposure that gets to the inner ear."

Scientists Spot Three More Genes Linked to Glaucoma Risk
January 11, 2016 (U.S. News & World Report Health)
The discovery of three more genes linked to the most common type of glaucoma could boost efforts to fight the eye disease, according to Janey Wiggs, Ph.D., and researchers from Massachusetts Eye and Ear/Harvard Medical School and Case Western Reserve University School of Medicine. The three newly identified genes associated with primary open angle glaucoma bring the total number of such genes to 15, according to the study published online Jan. 11 in Nature Genetics.

DeafTalent Everywhere!
January 6, 2016 (Huffington Post)
Mass. Eye and Ear optometrist Andrew Baker, O.D., was recognized by the Huffington Post for empowering others in the deaf community. Dr. Baker is a deaf optometrist specializing in accessible comprehensive eye care for deaf people.